Connect with us

Published

on

Elon Musk’s startup Neuralink streamed a live video on Wednesday that showed a patient using the company’s brain implant to move a mouse and play chess on a computer.

Noland Arbaugh, 29, is the first human patient to ever get implanted with Neuralink’s device. The company is developing a brain-computer interface, or a BCI, that aims to help patients with severe paralysis control external technologies using only neural signals. Neuralink’s first product is called Telepathy, Musk said in a post on his social media site X in January.

In the video Wednesday, which was streamed on X, Arbaugh said he became a quadriplegic after suffering a diving accident around eight years ago. He said the surgery to get Neuralink’s implant, which requires patients to remove a portion of their skull to insert electrodes into the brain tissue, was “super easy.” He was released from the hospital the next day, he said.

“It’s not perfect, I would say that we have run into some issues,” Arbaugh said. “I don’t want people to think that this is the end of the journey, there’s still a lot of work to be done, but it has already changed my life.”

A BCI is a system that deciphers brain signals and translates them into commands for external technologies. If the system functions properly, patients with severe degenerative diseases like ALS could eventually text or scroll through social media with their minds.

Several companies like Paradromics, Synchron, Blackrock Neurotech and Precision Neuroscience have developed BCI systems with these capabilities, and many of them have also implanted devices in human patients. Neuralink is particularly well known in the field due to the high profile of Musk, who is also the CEO of Tesla and SpaceX.

In many ways, the capabilities Neuralink demonstrated in its video Wednesday are not new. Dr. Nader Pouratian, chair of the Department of Neurological Surgery at UT Southwestern Medical Center, said researchers have been developing and studying BCI technology for years.

“There are things that we’ve been able to do for decades, like control a cursor in two dimensions, which actually, for those of us who are in the field, is extremely simple to do as soon as you can get any brain signal,” he told CNBC in an interview earlier this month.

He said there is a lot of excitement around BCIs, but admitted there is a host of practical challenges to work out, like how to interpret and analyze brain signals and make them useful. Pouratian said he thinks transparency from both academia and the broader BCI industry about advancements will be key for progress.

Neuralink began recruiting patients for its first in-human clinical trial in the fall after it received approval from the U.S. Food and Drug Administration to conduct the study in May 2023, according to a blog post. In January, Musk said the company implanted its device in a human for the first time, and that the patient, now revealed to be Arbaugh, was “recovering well,” according to a post on X.

Aside from Musk’s posts, Neuralink has shared very few details about the scope or the nature of its trial. As of Wednesday, the trial is not listed on the website clinicaltrials.gov, which is where most medical device companies share information about their research to help inform the public and other health-care professionals about their ambitions.

It is not clear how many patients are participating in Neuralink’s trial, or what the trial is trying to demonstrate. The company will have to go through several rounds of safety and efficacy testing before it can get the FDA’s final seal of approval and go to market.

Neuralink did not respond to CNBC’s request for comment.

There is reason to be hopeful about Neuralink’s technology, said Dr. Marco Baptista, chief scientific officer of the Christopher & Dana Reeve Foundation, which provides resources to people who have become paralyzed. He told CNBC in early March that BCI technology could make a meaningful impact on patients, but like all emerging devices, Neuralink’s system should be regarded with skepticism.

He said he would like to see more traditional scientific reports from Neuralink to learn more about its technology, for instance. Neuralink is listed as an author on one white paper from 2019, according to PubMed.

“I’m hopeful that this information will start to come out through these mechanisms that are needed in science, and that is through peer reviewed publications,” Baptista said. “That hasn’t happened yet. Other companies are doing it.”

Continue Reading

Technology

AI valuation fears grip global investors as tech bubble concerns grow

Published

on

By

AI valuation fears grip global investors as tech bubble concerns grow

A trader works on the floor of the New York Stock Exchange on Oct. 30, 2025 in New York.

Angela Weiss | AFP | Getty Images

This week’s equity market wobble, which saw a retreat in U.S. artificial intelligence-related stocks amid ongoing concerns over stretched valuations, has thrust contagion fears into the spotlight for global investors.

Goldman Sachs CEO David Solomon warned this week of a “likely” 10-20% drawdown in equity markets at some point within the next two years, while the International Monetary Fund and the Bank of England have both sounded the alarm bells.

Bank of England Governor Andrew Bailey highlighted the possibilities of an AI bubble in an interview with CNBC on Thursday, noting that the “very positive productivity contribution” from technology companies could be offset by uncertainty around future earning steams in the sector.

“We have to be very alert to these risks,” Bailey said.

Legrand is one of several European companies which is benefitting from the AI boom. The French company, which sells products to Alphabet, Amazon and others to help cool servers, has seen its shares surge 37% this year, roughly as much as Nvidia.

AI valuation fears are back and European stocks aren't immune

Anders Danielsson, CEO of Swedish construction group Skanska, which builds data centers and other AI infrastructure assets, shrugged off concerns about a slowdown.

“In the U.S. we have a very strong pipeline of data centers — we don’t see any slowdown there,” he told CNBC. “We are working with large international customers and they are also interested in building data centers in central Europe, and in the Nordics and the U.K. We haven’t seen any slowdown really.”

Meanwhile Kiran Ganesh, multi-asset strategist at UBS, highlighted a notable lack of volatility, adding that the broader narrative remains positive.

“We’ve had a remarkably smooth rally given the scale of investment that’s taken place, given the uncertainty about future cash flows, and given some of those concerns about valuation,” Ganesh told CNBC’s “Europe Early Edition” on Friday.

“As we’ve gone through earnings season, I think it’s reasonable to have expected some volatility, but actually when we look at the results, and they have been reassuring, we’re still up over the course of earnings season and they have been beating expectations. So although some volatility has been materializing this week, we think that’s to be expected and the bigger picture still remains positive.”

Still, many investors appear to be souring on the increasingly-stretched valuations.

In Asia, shares of SoftBank Group — which is active across AI infrastructure, semiconductor and application companies — have fallen sharply, with the Japanese group suffering almost $50 billion in weekly losses. SoftBank resumed its downward trajectory on Friday, after dropping about 10% on Wednesday.

On Tuesday, it emerged that Scion Asset Management, the hedge fund led by “The Big Short” investor Michael Burry, had built short positions against both Palantir Technologies and Nvidia, drawing the ire of Palantir CEO Alex Karp.

“Some big tech stocks are on sale, and are presenting buying opportunities for investors, especially for investors who have missed out on the market’s strength over the past two months,” said Glen Smith, chief investment officer at GDS Wealth Management.

Other investors have flagged concentration risk in U.S. equities, and advocate looking further afield.

Luca Paolini, chief strategist at Pictet Asset Management, said stretched valuations mean the firm is neutral on U.S. names. “Emerging markets are preferred, with diversified exposure across India, Brazil, and broader EM benefiting from AI-driven investment and monetary easing,” Paolini said in a market commentary.

Continue Reading

Technology

CEO of Southeast Asia’s largest bank warns investors: ‘Buckle up, we’re in for a volatile ride’

Published

on

By

CEO of Southeast Asia's largest bank warns investors: 'Buckle up, we're in for a volatile ride'

Tan Su Shan is the CEO and director of DBS Group.

Bloomberg | Bloomberg | Getty Images

With valuations in the U.S. stock market becoming increasingly stretched, the chief executive of Southeast Asia’s largest bank is warning investors to expect turbulence ahead.

“We’ve seen a lot of volatility in the markets. It could be equities, it could be rates, it could be foreign exchange,” DBS CEO Tan Su Shan told CNBC, adding that she expects that volatility to continue.

Tan, who took over the helm of DBS from longtime CEO Piyush Gupta in March, said that investors were particularly worried about the lofty valuations of artificial intelligence stocks, especially the so-called “Magnificent Seven.”

The Magnificent Seven — Amazon, Alphabet, Meta, Apple, Microsoft, Nvidia and Tesla — are some of the major U.S. tech and growth stocks that have driven much of Wall Street’s gains in recent years.

“You’ve got trillions of dollars tied up in seven stocks, for example. So it’s inevitable, with that kind of concentration, that there will be a worry about. ‘You know, when will this bubble burst?'”

Earlier this week, at the Global Financial Leaders’ Investment Summit in Hong Kong,  it was likely there would be a 10%-20% drawdown over the next 12 to 24 months.

Morgan Stanley CEO Ted Pick said at the same summit that investors should welcome periodic pullbacks, calling them healthy developments rather than signs of crisis.

Tan agreed. “Frankly, a correction will be healthy,” she said.

Recent examples include Advanced Micro Devices and Palantir, both of which posted stronger-than-expected quarterly results on Tuesday, yet their shares — and the wider Nasdaq — fell.

Her remarks follow similar warnings by the International Monetary Fund and central bank chiefs Jerome Powell and Andrew Bailey, who have all cautioned about inflated stock prices.

Singapore as diversification play

Tan advised investors to diversify rather than concentrate holdings in one market. “Whether it’s in your portfolio, in your supply chain, or in your demand distribution, just diversify.”

Tan, who has over 35 years of experience in banking and wealth management, noted that Asia could attract more investment from the U.S.—and that it’s not a bad thing.

Singling out Singapore and the country’s central bank’s efforts to boost interest in the local markets, Tan described the city-state as a “diversifier market.”

“We’ve got rule of law. We’re a transparent, open financial system and stable politically. We’re a good place to invest…. So I don’t think we’re a bad place to think about diversifying your investments.”

Stock Chart IconStock chart icon

hide content

Continue Reading

Technology

Elon Musk says Tesla needs to build ‘gigantic chip fab’ to meet AI and robotics needs

Published

on

By

Elon Musk says Tesla needs to build 'gigantic chip fab' to meet AI and robotics needs

Tesla CEO Elon Musk attends the Saudi-U.S. Investment Forum, in Riyadh, Saudi Arabia, May 13, 2025.

Hamad I Mohammed | Reuters

Tesla CEO Elon Musk says the company will likely need to build a “gigantic” semiconductor fabrication plant to keep up with its artificial intelligence and robotics ambitions.

“One of the things I’m trying to figure out is — how do we make enough chips?” Musk said at Tesla’s annual shareholders meeting Thursday.

Tesla currently relies on contract chipmakers Taiwan Semiconductor Manufacturing Company and Samsung Electronics to produce its chip designs. Musk said he was also considering working with U.S. chip company Intel

“But even when we extrapolate the best-case scenario for chip production from our suppliers, it’s still not enough,” he said.

Tesla would probably need to build a “gigantic”  chip fab, which Musk described as a “Tesla terra fab.” “I can’t see any other way to get to the volume of chips that we’re looking for.” 

Microchips are the brains that power almost all modern technologies, including everything from consumer electronics like smartphones to massive data centers, and demand for them has been surging amid the AI boom.

Tech giants, including Tesla, have been clamoring for more supply from chipmakers like TSMC — the world’s largest and most advanced chipmaker. 

According to Musk, Tesla’s potential fab’s initial capacity would reach 100,000 wafer starts per month and eventually scale up to 1 million. In the semiconductor industry, wafer starts per month is a measure of how many new chips a fab produces each month.

For comparison, TSMC says its annual wafer production capacity reached 17 million in 2024, or around 1.42 million wafer starts per month.

While Tesla doesn’t yet manufacture its own microchips, the company has been designing custom chips for autonomous driving for several years.

It is currently outsourcing production of its latest-generation “AI5” chip, which Musk said will be cheaper, power-efficient, and optimized for Tesla’s AI software.

The CEO also announced on Thursday that Tesla will begin producing its Cybercab — an autonomous electric vehicle with no pedals or steering wheel — in April.

Musk’s statements underscore Tesla’s shift into AI and robotics — industries the CEO sees as the future of the global economy. 

“With AI and robotics, you can actually increase the global economy by a factor of 10, or maybe 100. There’s not, like, an obvious limit,” Musk said at the shareholder meeting. 

Continue Reading

Trending